The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 355:528-529 August 3, 2006 Number 5
NextNext

COX-2 Inhibitors and Early Failure of Free Vascular Flaps

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
To the Editor: We wish to report our clinical experience with the use of cyclooxygenase-2 (COX-2) inhibitors to control pain in patients treated with free vascular flaps after undergoing ablative surgery to resect an oral cancer. From January 1997 to February 2004, all patients who underwent ablative surgery at Helsinki University Central Hospital to resect a cancer, followed by surgical reconstruction of the maxillofacial skeleton with the use of a free vascular flap, received 2000 IU of dalteparin per kilogram of body weight twice daily and opioid medications, without the use of selective COX-2 inhibitors, as approved by the institutional . . . [Full Text of this Article]


This article has been cited by other articles:


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.